Domagoj Vucic

机构：University of Slavonski Brod · ORCID：0000-0003-3614-8093

发表论文 144 篇 · 总被引 24432 次 · h-index 59

代表论文

• Apoptotic cell death in disease—Current understanding of the NCCD 2023 (2023 · Cell Death and Differentiation · 被引 376)
• Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer (2024 · Cell Reports Medicine · 被引 59)
• cIAPs control RIPK1 kinase activity‐dependent and ‐independent cell death and tissue inflammation (2023 · The EMBO Journal · 被引 25)
• A phase I, randomized, ascending‐dose study to assess safety, pharmacokinetics, and activity of GDC‐8264, a RIP1 inhibitor, in healthy volunteers (2023 · Clinical and Translational Science · 被引 21)
• Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects (2023 · Science Translational Medicine · 被引 19)
• RIP1 inhibition protects retinal ganglion cells in glaucoma models of ocular injury (2024 · Cell Death and Differentiation · 被引 18)